News

According to the lawsuit, FDA has knowingly allowed sodium thiopental, which has not been approved by the FDA, to be imported by state corrections agencies for use in

For the fourth quarter of 2010, the company posted an operating income of $367.4m, compared to $316.9m for the same period in 2009. For the full year ended

The company has successfully completed two Phase I trials of EGEN-001, in which the treatment resulted in good safety, biological activity and encouraging efficacy. EGEN-001 received Orphan Drug

Fera Pharma is launching Puralube in a 3.5g tube as well as a carton of 20 1g tubes. Fera Pharmaceuticals has launched its over-the-counter (OTC) dry eye treatment,

Shire claims that Vyvanse is the first and only once-daily prodrug stimulant approved to treat ADHD in adolescents and adults. The FDA’s approval of Vyvanse in adolescents and

Pilgrim’s Document Management solution will replace a paper-based system to better manage Megadyne’s increasing volume of documentation and related change controls by enabling the company to effectively create,

ICT-107 is the company’s dendritic cell based cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM). The study will enroll approximately 100 patients, and will be conducted

Merck will examine magentic beads coated with CardioGenics’ silver-coating and polymer encapsulation processes while refining encapsulation of the beads. The silver-coating technology of the CardioGenics enhances the signaling

The court found Actavis and co-defendant Actavis Elizabeth to have misrepresented its drug prices to Medicaid. The decision came after Florida-based pharmacy Ven-a-Care filed a whistleblower lawsuit under